NAVLE Multisystemic

Bovine Viral Diarrhea (BVD) and Mucosal Disease – NAVLE Study Guide

Bovine Viral Diarrhea (BVD) is one of the most economically significant infectious diseases affecting cattle worldwide.

Overview and Clinical Importance

Bovine Viral Diarrhea (BVD) is one of the most economically significant infectious diseases affecting cattle worldwide. Caused by Bovine Viral Diarrhea Virus (BVDV), a member of the genus Pestivirus within the family Flaviviridae, this disease causes immunosuppression, reproductive losses, respiratory disease, and gastrointestinal disorders. Despite its name, BVD does not specifically affect the digestive tract but rather has immunosuppression as its hallmark feature.

Mucosal Disease (MD) is a distinct, invariably fatal syndrome that occurs only in persistently infected (PI) cattle when they become superinfected with a cytopathic biotype of BVDV. Understanding the relationship between BVD and MD is critical for NAVLE success.

Classification Characteristics Clinical Significance
BVDV-1 (Pestivirus A) 24+ subgenotypes (1a-1x); predominant worldwide Generally causes milder disease; most common in Europe
BVDV-2 (Pestivirus B) 4 subgenotypes (2a-2d); 50% of North American cases Associated with severe acute disease, thrombocytopenic syndrome
Noncytopathic (NCP) No visible cytopathic effect in cell culture; establishes persistent infection ONLY biotype that causes persistent infection; most common in nature
Cytopathic (CP) Causes cell death, vacuolation in culture within 2-3 days Required for mucosal disease development; arises from NCP mutation

Etiology and Classification

Virus Classification

BVDV is classified within the Pestivirus genus, which also includes Border Disease Virus (sheep) and Classical Swine Fever Virus (pigs). The virus is a small (40-60 nm), enveloped, single-stranded positive-sense RNA virus.

BVDV Genotypes and Biotypes

High-YieldFor the NAVLE, remember: Only NONCYTOPATHIC BVDV causes persistent infection. Mucosal disease requires BOTH biotypes - the PI animal must be infected with NCP virus AND then superinfected with antigenically homologous CP virus.
Gestational Period Fetal Immune Status Outcome
Less than 40 days Pre-implantation/early embryo Embryonic death, resorption, return to estrus, infertility
40-125 days (CRITICAL) Immunologically naive; fetal immune system not developed PERSISTENT INFECTION - virus recognized as self, immunotolerance develops
100-150 days Organogenesis ongoing; partial immune competence CONGENITAL DEFECTS: cerebellar hypoplasia, hydranencephaly, ocular defects, alopecia
Greater than 150-180 days Immunocompetent fetus Abortion, stillbirth, or normal calf with precolostral antibodies

Pathogenesis

Transmission Routes

Horizontal transmission: Direct contact with infected cattle, nasal/oral secretions, feces, urine, milk, semen, and contaminated fomites. PI animals shed virus continuously at 1000x the level of acutely infected animals.

Vertical transmission: Transplacental infection is the key mechanism for creating PI animals. The outcome depends critically on gestational timing.

Critical Gestational Windows and Fetal Outcomes

NAVLE TipThe 40-125 day window is the CRITICAL period for PI calf creation. Remember '40 to 125 = PI alive' - infection during this period before fetal immunocompetence leads to immunotolerance and lifelong viral shedding.

Persistently Infected (PI) Animals

PI animals are the cornerstone of BVDV epidemiology and serve as the primary reservoir for viral transmission. Key characteristics include:

  • Born immunotolerant to their infecting NCP BVDV strain - virus recognized as self
  • Shed massive quantities of virus continuously through all body secretions
  • Typically seronegative (no antibodies) unless vaccinated or superinfected with heterologous strain
  • Often unthrifty, poor doers, but may appear clinically normal
  • Only 20% survive to 2 years of age; high susceptibility to secondary infections
  • PI dams ALWAYS produce PI offspring

Mucosal Disease Pathogenesis

Mucosal disease (MD) is a uniformly fatal condition that can ONLY develop in PI animals. It occurs when a PI animal becomes superinfected with a cytopathic (CP) biotype of BVDV that is antigenically similar to their resident NCP virus.

Sources of CP Virus

  • Internal mutation (most common): The resident NCP virus undergoes spontaneous recombination or mutation to become CP
  • External exposure: Contact with other cattle shedding CP virus
  • MLV vaccination: Modified-live BVDV vaccines containing CP virus (rare)

Because the PI animal is immunotolerant to its resident NCP virus, it cannot mount an immune response against the antigenically similar CP virus. The CP virus spreads to GI epithelium, causing keratinocyte necrosis, erosion, and ulceration throughout the alimentary tract.

High-YieldOn the NAVLE, when you see a young animal (6-24 months) with profuse diarrhea, oral ulcerations, and rapid deterioration - THINK MUCOSAL DISEASE IN A PI ANIMAL. The key diagnostic clue is finding BOTH NCP and CP biotypes in tissues at necropsy.
Syndrome Affected Animals Key Clinical Signs Prognosis
Subclinical/Mild Acute BVD Immunocompetent cattle (most common) Often inapparent; mild fever, transient leukopenia, reduced milk production Good; recovery in 1-3 weeks with antibody development
Severe Acute BVD Naive cattle, often BVDV-2 infection High fever (41-42 C), bloody diarrhea, oral ulcers, thrombocytopenia, hemorrhages Guarded to poor; 25% or greater mortality
Acute Mucosal Disease PI cattle only; typically 6-24 months old Profuse watery/bloody diarrhea, extensive oral ulcers, severe dehydration, death in 5-10 days FATAL - 100% mortality
Chronic Mucosal Disease PI cattle only Intermittent diarrhea, progressive wasting, lameness (interdigital lesions), alopecia FATAL - weeks to months
Reproductive BVD Pregnant cattle Abortion, stillbirth, mummification, congenital defects, birth of PI calves Variable; dam typically recovers

Clinical Presentations

Summary of BVD Clinical Syndromes

Mucosal Disease Clinical Findings

Classic Presentation

  • Sudden onset depression, fever, and complete anorexia
  • Hypersalivation (excessive salivation with drooling)
  • Oral ulcerations: Erosions on muzzle, dental pad, tongue, hard palate, gums
  • Nasal discharge: Serous to mucopurulent, with nasal erosions
  • Profuse watery diarrhea: Contains blood, mucus, and mucosal shreds in terminal stages
  • Lameness: Coronitis and interdigital skin erosions/ulceration
  • Rapid weight loss and severe dehydration leading to death in 5-10 days

Congenital Defects (Fetal Infection 100-150 Days)

NAVLE TipWhen you see a newborn calf with ataxia, wide-based stance, tremors, and inability to stand - think CEREBELLAR HYPOPLASIA from BVDV infection at 120-150 days gestation. Also consider other viral teratogens like Akabane virus and Schmallenberg virus in the differential.
CNS Defects Ocular Defects Other Defects
Cerebellar hypoplasia (most common) Hydranencephaly Hydrocephalus Porencephaly Hypomyelination Cataracts Microphthalmia Retinal dysplasia/degeneration Optic neuritis Thymic hypoplasia Alopecia/hypotrichosis Brachygnathism Growth retardation Pulmonary hypoplasia

Pathological Findings

Gross Pathology of Mucosal Disease

  • Oral cavity: Erosions and ulcerations on tongue (especially lateral borders), dental pad, hard palate, gums, and pharynx
  • Esophagus: Characteristic LINEAR erosions and ulcerations along mucosal folds
  • Rumen: Erosions on pillars and papillae
  • Abomasum: Mucosal edema and rounded ulcerations
  • Small intestine: Erosions over PEYER'S PATCHES (hallmark finding), hemorrhagic mucosa
  • Large intestine: Ulcerations in cecum, proximal colon, and rectum
  • Lymphoid tissue: Mesenteric lymph node enlargement, edema; thymic atrophy
  • Skin: Coronitis, interdigital erosions, occasional alopecia
High-YieldThe combination of LINEAR ESOPHAGEAL EROSIONS + PEYER'S PATCH ULCERATION is highly suggestive of mucosal disease. This distinguishes MD from other erosive diseases like rinderpest or malignant catarrhal fever.

Histopathology

  • Necrosis of keratinocytes in stratum spinosum of epithelium
  • Intestinal crypt necrosis
  • Severe lymphoid depletion in Peyer's patches and lymph nodes
  • Viral antigen demonstrable in epithelial cells by IHC
Test Sample Type Best Use Key Considerations
Antigen-Capture ELISA (ACE) Ear notch, serum, buffy coat PI detection; individual animal testing PI-specific with repeat testing; maternal antibody may interfere in young calves
RT-PCR Ear notch, blood, bulk milk, tissue Pooled screening; genotyping; acute and PI detection Most sensitive; can pool samples (reduces cost); detects both TI and PI
Immunohistochemistry (IHC) Formalin-fixed ear notch, tissue PI confirmation; necropsy diagnosis PI-specific; visualizes antigen in tissue; gold standard for tissue diagnosis
Virus Isolation Buffy coat, serum, tissue Biotype determination; research Distinguishes NCP from CP; time-consuming; maternal Ab interferes
Serology (ELISA, VN) Serum, bulk milk Herd exposure status; paired samples for acute infection Detects past exposure; PI animals typically seronegative; 4-fold rise confirms acute

Diagnosis

Diagnostic Testing Overview

PI Animal Detection Protocol

The Ear Notch Test is the most practical method for PI detection in the field:

  • Collect dime-sized ear notch sample at tagging (can use ear tag tissue plug)
  • Test by pooled RT-PCR (pools of 10-36) or individual ACE
  • If positive pool, test individual samples by ACE or IHC
  • CRITICAL: Retest positive animals at least 3 weeks later to confirm PI status
  • Two positive results at greater than or equal to 3 weeks apart = CONFIRMED PI
NAVLE TipWhy retest at 3 weeks? To differentiate PI from transiently infected (TI) animals. TI animals clear virus within 2-3 weeks and seroconvert. PI animals remain virus-positive and seronegative indefinitely. A negative BVD-PI test = negative for LIFE (once confirmed).

Mucosal Disease Diagnosis

The diagnosis of MD is confirmed by:

  • Clinical signs + characteristic gross pathology
  • Isolation of BOTH NCP and CP BVDV biotypes from tissues
  • The paired viruses are antigenically similar (homologous)
  • Animal is typically seronegative (no antibodies) unless recently superinfected with heterologous strain

Differential Diagnosis

Mucosal disease must be differentiated from other erosive/ulcerative diseases:

Disease Key Distinguishing Features Geographic/Regulatory Status
Rinderpest Very similar; historically major concern; lymphoid necrosis, erosive stomatitis ERADICATED WORLDWIDE (2011); reportable if suspected
Malignant Catarrhal Fever Corneal opacity (blue eye), head and eye form; lymphoproliferative; sporadic Sporadic occurrence; sheep/wildebeest association
Foot-and-Mouth Disease VESICLES (not erosions); high morbidity, low mortality; affects feet, mouth, teats FOREIGN ANIMAL DISEASE in USA; reportable
Vesicular Stomatitis Vesicles on oral mucosa, tongue, teats; seasonal (summer); horses also affected Reportable disease; endemic in Americas
Bluetongue Primarily sheep; swollen blue tongue; coronitis; vector-borne (Culicoides) Cattle typically subclinical; reportable

Treatment

CRITICAL: There is NO specific treatment for BVD or mucosal disease. Management is strictly supportive:

Condition Management Approach
Acute BVD Supportive care: IV fluids, electrolytes, anti-inflammatories Antibiotics for secondary bacterial infections Most immunocompetent animals recover in 1-3 weeks
PI Animals IMMEDIATE REMOVAL from herd - no treatment can clear infection Options: Humane euthanasia, sale to slaughter only, isolation until slaughter NEVER sell PI animals at auction (unethical)
Mucosal Disease HUMANE EUTHANASIA upon diagnosis - disease is 100% fatal Supportive care only prolongs suffering Report to regulatory authorities if foreign animal disease cannot be ruled out

Prevention and Control

Vaccination

Recommended Vaccination Protocol

  • Heifers: Vaccinate 2-4 weeks BEFORE breeding with MLV vaccine
  • Pregnant cows: Use only KILLED vaccines if vaccination during pregnancy is necessary
  • Bulls: Test for PI status before purchase; vaccinate annually
  • Calves: Initial vaccination at 6-8 months when maternal antibodies wane
  • Boosters: MLV annually; killed vaccine every 4-6 months

Herd Control and Eradication Strategies

  • Test and Remove: Identify and eliminate ALL PI animals - cornerstone of eradication
  • Biosecurity: Test all incoming animals for PI status before introduction
  • Closed herd: Maintain closed herd or source from BVD-free accredited herds only
  • Vaccination: Vaccinate ALL breeding cattle to prevent fetal infection and PI calf production
  • Surveillance: Test all calves at birth (ear notch); bulk tank milk monitoring in dairy herds
  • Fence line separation: Double perimeter fencing to prevent contact with neighbor cattle
High-YieldVaccination ALONE cannot eradicate BVD - it reduces but does not eliminate PI calf production. The meta-analysis shows vaccination decreases fetal infection by 85% and abortion risk by 45%. Successful eradication REQUIRES identification and removal of ALL PI animals combined with vaccination.
Vaccine Type Advantages Disadvantages/Considerations
Modified-Live Virus (MLV) Rapid immunity (within 1 week) Single dose usually sufficient Longer duration of immunity Better fetal protection Stronger cell-mediated immunity NOT for pregnant animals (risk of fetal infection/PI calves) May induce MD in undiagnosed PI animals (rare) Transient immunosuppression possible More temperature-sensitive storage
Killed (Inactivated) Safe for ALL animals including pregnant cattle More stable storage No risk of inducing MD Requires 2 doses initially (2-3 weeks apart) Shorter duration of immunity (4-6 months) Reduced fetal protection Weaker cell-mediated response

Practice NAVLE Questions

Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.

Start Your Free Trial →